Prednisone use, disease activity and the occurrence of hyperglycaemia and diabetes in patients with early rheumatoid arthritis: a 10-year subanalysis of the BeSt study.
Joy Ardjuna van der PolCornelia F AllaartWillem F LemsSjoerd M van der KooijThomas Wj HuizingaSytske Anne BergstraPublished in: RMD open (2024)
In non-diabetic early RA patients, the use of prednisone was not associated with developing hyperglycaemia or diabetes. However, high DAS increased the risk of diabetes. Potential risks associated with prednisone use may have been mitigated by its effect on DAS.
Keyphrases
- disease activity
- rheumatoid arthritis
- type diabetes
- systemic lupus erythematosus
- rheumatoid arthritis patients
- ankylosing spondylitis
- cardiovascular disease
- glycemic control
- juvenile idiopathic arthritis
- end stage renal disease
- ejection fraction
- newly diagnosed
- risk assessment
- chronic kidney disease
- peritoneal dialysis
- human health
- adipose tissue
- patient reported outcomes
- insulin resistance
- idiopathic pulmonary fibrosis
- climate change